哌替啶（度冷丁）市場：依劑型、應用、通路和地區分類

Meperidine (Demerol) Market, By Form, By Application, By Distribution Channel, and By Region

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，哌替啶（度冷丁）市值將達到 5.165 億美元，到 2033 年將達到 5.812 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 1.7%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	5.165億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	1.70	2033年市場規模預測：	5.812億美元

哌替啶（商品名：度冷丁）是一種苯基哌啶類合成鴉片類止痛藥，用於治療中度至重度疼痛。它以鹽酸鹽片劑或糖漿劑型給藥，也可透過肌肉注射、皮下注射或靜脈注射給藥。由於其存在毒性代謝物去甲哌替啶，長期使用哌替啶的毒性高於其他鴉片類藥物。去甲哌替啶具有血清素能作用，可能導致血清素症候群的發生。哌替啶在分娩期間廣泛用於鎮痛。由於其能降低腸腔內壓力，哌替啶也是治療憩室炎的首選止痛藥。此外，哌替啶也用於治療性低溫療法，以抑制寒顫，因為它能最有效地降低寒顫閾值。哌替啶可與多種其他藥物產生交互作用，包括肌肉鬆弛劑、苯二氮平類藥物和乙醇。哌替啶的副作用主要與鴉片類藥物的常見副作用通用，包括噁心、嘔吐、頭暈、出汗、閉尿症和便秘。

市場動態：

對哌替啶需求的成長、與哌替啶合成相關的研發活動以及新產品的上市正在成長要素。例如，根據歐洲統計局（一家歐洲政府機構）2022年7月發布的數據，2020年歐盟至少進行了112萬例剖腹產手術。哌替啶是一種廣泛用於治療分娩疼痛和手術鎮痛的藥物。因此，手術數量的增加可能會提振對哌替啶的需求，並在預測期內推動市場成長。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球哌替啶（度冷丁）市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本研究涵蓋的主要公司包括輝瑞、Hikma Pharmaceuticals USA、Epic Pharma、Vintage Pharmaceuticals、賽諾菲、強生製藥、勃林格殷格翰、太陽製藥、Egarett Corporation 和 Mallinckrod Pharmaceuticals。
本報告提供的見解將有助於各公司的行銷負責人和經營團隊就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球哌替啶（度冷丁）市場報告針對該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球哌替啶（度冷丁）市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Pfizer, Inc.
Hikma Pharmaceuticals USA Inc.
Epic Pharma, Inc.
Vintage Pharmaceuticals, Inc
Sanofi
Pfizer, Inc.
Hikma Pharmaceuticals USA Inc.
Epic Pharma, Inc.
Vintage Pharmaceuticals, Inc.
Sanofi
Janssen Pharmaceuticals
Boehringer Ingelheim
Sun Pharmaceutical
Egalet Corporation
Mallinckrodt Pharmaceuticals

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI3816

Meperidine (Demerol) Market is estimated to be valued at USD 516.5 Mn in 2026 and is expected to reach USD 581.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 1.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 516.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	1.70%	2033 Value Projection:	USD 581.2 Mn

Pethidine or meperidine is sold under the brand name of Demerol and it is a synthetic opioid pain medication of phenylpiperidine class. Meperidine is indicated for the treatment of moderate to severe pain. It can be administered as hydrochloride salt in tablets, as a syrup or by intramuscular, subcutaneous or intravenous injection. Due to its toxic metabolite, norpethidine, it is more toxic than other opioid in long term usage. The metabolite of drug has serotonergic effect that could contribute to serotonin syndrome. Meperidine is a widely used opioid in labor and delivery. Meperidine is the preferred painkiller for diverticulitis because it decreases the intestinal intraluminal pressure. This drug is also used for the management of shivering during therapeutic hypothermia, as it provides the greatest reduction in the shivering threshold. It is probable that meperidine can also interact with a number of other medications including muscle relaxants, benzodiazepines, and ethanol. The adverse effects of meperidine administration are primarily those of the opioids as a class: nausea, vomiting, dizziness, diaphoresis, urinary retention, and constipation.

Market Dynamics:

The increasing demand for meperidine, research and development activities in synthesis of meperidine, and the launch of new products are attributed to the growth of the global meperidine (Demerol) market. For instance, according to data shared by European statistical System, a European government agency, on July 2022, at least 1.12 million caesarean sections were performed in the European Union in year 2020. Meperidine is a commonly used drug for the treatment of labor pain and operations. Hence increased surgeries can increase the demand for meperidine and boost the market growth over the forecast period.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Meperidine (Demerol) market based on the following parameters - Company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Pfizer, Inc., Hikma Pharmaceuticals USA Inc., Epic Pharma, Inc., Vintage Pharmaceuticals, Inc., Sanofi, Janssen Pharmaceuticals, Boehringer Ingelheim, Sun Pharmaceutical, Egalet Corporation, and Mallinckrodt Pharmaceuticals.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Meperidine (Demerol) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Meperidine (Demerol) market

Detailed Segmentation:

Global Meperidine (Demerol) Market, By Form (Revenue, USD Mn, 2021 - 2033)
Tablet
Injection
Syrup
Global Meperidine (Demerol) Market, By Application (Revenue, USD Mn, 2021 - 2033)
Anesthesia
Cough Treatment
Diarrhea Treatment
Global Meperidine (Demerol) Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Meperidine (Demerol) Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
Pfizer, Inc.
Hikma Pharmaceuticals USA Inc.
Epic Pharma, Inc.
Vintage Pharmaceuticals, Inc.
Sanofi
Janssen Pharmaceuticals
Boehringer Ingelheim
Sun Pharmaceutical
Egalet Corporation
Mallinckrodt Pharmaceuticals

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Form
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Meperidine (Demerol) Market, By Form, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Tablet
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Syrup
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

5. Global Meperidine (Demerol) Market, By Application, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Anesthesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Cough Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Diarrhea Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

6. Global Meperidine (Demerol) Market, By Distribution Channel, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

7. Global Meperidine (Demerol) Market, By Region, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hikma Pharmaceuticals USA Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Epic Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Vintage Pharmaceuticals, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hikma Pharmaceuticals USA Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Epic Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Vintage Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Janssen Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sun Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Egalet Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies